M
Matti Ojamo
Researcher at National Institutes of Health
Publications - 16
Citations - 326
Matti Ojamo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Visual impairment & Population. The author has an hindex of 7, co-authored 13 publications receiving 252 citations.
Papers
More filters
Journal ArticleDOI
Inverse association between breast cancer incidence and degree of visual impairment in Finland.
TL;DR: Breast cancer risk decreased by degree of visual impairment (P for trend 0.04) which suggests a dose–response relationship between visible light and breast cancer risk.
Journal ArticleDOI
Visual impairment and cancer: a population-based cohort study in Finland
TL;DR: Cancer incidence among the visually impaired tended to be increased for most cancer types, and attention should be paid to lifestyle factors underlying the observed risk increases, such as unbalanced diet.
Journal ArticleDOI
Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment.
TL;DR: The hypothesis that blind persons are at lower risk of cancer in a follow-up study linking a cohort of 17,557 persons with visual impairment with cancer incidence data of the Finnish Cancer Registry is tested and the result is strongly against the hypothesis of a systemic protective effect related lack of visible light.
Journal ArticleDOI
Low vision status and declining vision decrease Health-Related Quality of Life: Results from a nationwide 11-year follow-up study
Joonas Taipale,Alexandra Mikhailova,Matti Ojamo,Janika Nättinen,Saku Väätäinen,Mika Gissler,Mika Gissler,Seppo Koskinen,Harri Rissanen,Päivi Sainio,Hannu Uusitalo +10 more
TL;DR: In this article, the impact of visual acuity (VA) on health-related quality of life (HRQoL) and the cross-sectional and longitudinal differences in HRQOL during the 11-year follow-up were investigated.
Low vision status and declining vision decrease Health-Related Quality of Life: Results from a nationwide 11-year follow-up study
Joonas Taipale,Alexandra Mikhailova,Matti Ojamo,Janika Nättinen,Saku Väätäinen,Mika Gissler,Mika Gissler,Seppo Koskinen,Harri Rissanen,Päivi Sainio,Hannu Uusitalo +10 more
TL;DR: HRQoL was significantly and meaningfully impaired even before the threshold of severe vision loss or blindness was reached, and the results encourage the improvement of available treatment options aiming to postpone the onset of visual impairment or declining VA, to maintain better quality of life among the population.